Search

everythinglearnresearchcommunity

for

Search:↓

Optimal conditions for extracting beneficial compounds from Carthamus caeruleus L. rhizomes were identified, improving efficiency.

Researchers developed a method to measure active ingredients in a hair loss treatment cream.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

The hair tonic with cinnamon oil and coconut oil was stable and caused very mild irritation.

Hair transplant surgery effectively treated a specific type of hair loss and is recommended as a primary treatment option.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

The FDA rejected a testosterone drug again due to safety concerns.

Baricitinib helps with early hair regrowth in people with alopecia areata.

Triangular temporal alopecia is a benign hair loss pattern best diagnosed with dermoscopy, with limited treatment options like surgery and hair transplantation.

Lower doses of topotecan are safe for eyes, but higher doses may harm the retina.

The cream effectively treats acne without causing irritation.

Combining Traditional Chinese Medicine with Western treatments improves hair loss treatment.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

L-Carnitine-L-tartrate may help hair grow and prevent hair loss.

Imiquimod used intravaginally for cervical issues can cause temporary hair loss, especially if severe side effects occur.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

TA-Ado effectively promotes hair growth and reduces hair loss.

Cryptotanshinone may help treat postmenopausal osteoporosis and protect kidneys.

Baricitinib was effective in treating both early and late onset alopecia areata.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

The new formulation greatly improved quercetin absorption in rats.

TrichoScan® is a reliable tool for measuring hair growth, providing quicker and more consistent results than manual methods.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Trichoscopy can reliably distinguish between alopecia areata and trichotillomania.

A new test more accurately detects citrulline in hair follicles and pilomatrixomas.

Finasteride may reduce prostate cancer risk.

Measuring OPC-17116 in hair can reliably indicate drug exposure and timing.